Vessel co-option in glioblastoma: emerging insights and opportunities

被引:0
|
作者
Giorgio Seano
Rakesh K. Jain
机构
[1] PSL Research University,Tumor Microenvironment Laboratory, Institut Curie Research Center, Paris Saclay University
[2] Inserm U1021,Edwin L. Steele Laboratory, Department of Radiation Oncology
[3] CNRS UMR3347,undefined
[4] Massachusetts General Hospital and Harvard Medical School,undefined
来源
Angiogenesis | 2020年 / 23卷
关键词
Vessel co-option; Glioblastoma; Anti-angiogenesis; Cell migration; Tumor microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
Vessel co-option is the movement of cancer cells towards and along the pre-existing vasculature and is an alternative to angiogenesis to gain access to nutrients. Vessel co-option has been shown as a strategy employed by some glioblastoma (GBM) cells to invade further into the brain, leading to one of the greatest challenges in treating GBM. In GBM, vessel co-option may be an intrinsic feature or an acquired mechanism of resistance to anti-angiogenic treatment. Here, we describe the histological features and the dynamics visualized through intravital microscopy of vessel co-option in GBM, as well as the molecular players discovered until now. We also highlight key unanswered questions, as answering these is critical to improve understanding of GBM progression and for developing more effective approaches for GBM treatment.
引用
收藏
页码:9 / 16
页数:7
相关论文
共 50 条
  • [21] Regeneration and the voluntary sector: challenges, opportunities - co-operation or co-option?
    Diamond, John
    Liddle, Joyce
    INTERNATIONAL JOURNAL OF SOCIOLOGY AND SOCIAL POLICY, 2010, 30 (1-2) : 27 - 33
  • [22] Models and molecular mechanisms of blood vessel co-option by cancer cells
    Yu Zhang
    Sarah Wang
    Andrew C. Dudley
    Angiogenesis, 2020, 23 : 17 - 25
  • [23] Tumor vessel co-option probed by single-cell analysis
    Teuwen, Laure-Anne
    De Rooij, Laura P. M. H.
    Cuypers, Anne
    Rohlenova, Katerina
    Dumas, Sebastien J.
    Garcia-Caballero, Melissa
    Meta, Elda
    Amersfoort, Jacob
    Taverna, Federico
    Becker, Lisa M.
    Veiga, Nuphar
    Cantelmo, Anna Rita
    Geldhof, Vincent
    Conchinha, Nadine, V
    Kalucka, Joanna
    Treps, Lucas
    Conradi, Lena-Christin
    Khan, Shawez
    Karakach, Tobias K.
    Soenen, Stefaan
    Vinckier, Stefan
    Schoonjans, Luc
    Eelen, Guy
    Van Laere, Steven
    Dewerchin, Mieke
    Dirix, Luc
    Mazzone, Massimiliano
    Luo, Yonglun
    Vermeulen, Peter
    Carmeliet, Peter
    CELL REPORTS, 2021, 35 (11):
  • [24] Models and molecular mechanisms of blood vessel co-option by cancer cells
    Zhang, Yu
    Wang, Sarah
    Dudley, Andrew C.
    ANGIOGENESIS, 2020, 23 (01) : 17 - 25
  • [25] Vessel co-option is an essential phenomenon for vascularisation of colorectal liver metastasis
    Peeters, C
    de Waal, R
    Westphal, H
    Ruers, T
    ANNALS OF ONCOLOGY, 2006, 17
  • [26] Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
    Elizabeth A.Kuczynski
    Robert S.Kerbel
    Chinese Journal of Cancer, 2016, 35 (12) : 641 - 644
  • [27] Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
    Kuczynski, Elizabeth A.
    Kerbel, Robert S.
    CHINESE JOURNAL OF CANCER, 2016, 35 : 97
  • [28] Liver Metastases: "Vessel co-option" reduces the Effectiveness of Angiogenesis Inhibitors
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (03): : 244 - 245
  • [29] Emerging Powers and Small Island Developing States: Leadership or Co-Option?
    Din, Athar ud
    INDIA QUARTERLY-A JOURNAL OF INTERNATIONAL AFFAIRS, 2023, 79 (02): : 244 - 263
  • [30] Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma
    Ribatti, Domenico
    Pezzella, Francesco
    FRONTIERS IN ONCOLOGY, 2022, 12